A carregar...
Combination therapy with normobaric oxygen (NBO) plus thrombolysis in experimental ischemic stroke
BACKGROUND: The widespread use of tissue plasminogen activator (tPA), the only FDA-approved acute stroke treatment, remains limited by its narrow therapeutic time window and related risks of brain hemorrhage. Normobaric oxygen therapy (NBO) may be a useful physiological strategy that slows down the...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2714858/ https://ncbi.nlm.nih.gov/pubmed/19604385 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2202-10-79 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|